SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) shares passed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $156.99 and traded as high as $157.55. SPDR S&P Biotech ETF shares last traded at $157.51, with a volume of 9,094,154 shares trading hands.
SPDR S&P Biotech ETF Price Performance
The firm’s 50 day moving average price is $156.99 and its 200-day moving average price is $141.25. The firm has a market cap of $10.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.
Hedge Funds Weigh In On SPDR S&P Biotech ETF
Several large investors have recently bought and sold shares of XBI. Bank of America Corp DE grew its position in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. Main Street Research LLC lifted its stake in shares of SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after buying an additional 206,953 shares during the period. Strs Ohio lifted its stake in shares of SPDR S&P Biotech ETF by 4.9% in the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock valued at $52,433,000 after buying an additional 19,300 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of SPDR S&P Biotech ETF by 145.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after buying an additional 186,314 shares during the period. Finally, Annex Advisory Services LLC lifted its stake in shares of SPDR S&P Biotech ETF by 4.6% in the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after buying an additional 11,723 shares during the period.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}